bisphosphonates​2019

Celebrating 50 years

15-17 July 2019 - Sheffield, UK

Invitation!

Dear Colleagues,

The year 2019 will mark 50 years since the first publication on the biological effects of the bisphosphonates. Since then more than 27,000 papers have appeared on PubMed! We invite you to join us in Sheffield as we celebrate this golden anniversary. The meeting will review developments over the past 50 years, discuss our current understanding and look at what the future may hold.

The discovery that BPs could inhibit bone resorption led very quickly to their clinical use in Paget’s disease and in patients with skeletal complications of cancer and later in osteoporosis. They remain the major drugs used for these conditions and their use in clinical therapeutics is likely to continue well into the future.

Sheffield is England’s 5th largest city, and with its two universities has been voted the UK’s most popular student destination. It has a vibrant and diverse social scene, and at the same time is one of the UK’s greenest cities, with one third of the city lying within the Peak District National Park. Transport links are good and there is a choice of international airports within an hour of the city.

We look forward to welcoming you to Sheffield in July 2019!

Richard Eastell / Graham Russell
Meeting Chairs

Organising Committee

Co-Chairs: Richard Eastell (Sheffield, UK) / Graham Russell (Oxford and Sheffield, UK)

Nick Bishop (Sheffield, UK)
Janet Brown (Sheffield, UK)
Philippe Clézardin (Lyon, France, and Sheffield, UK)
Rob Coleman (Sheffield, UK)
Steve Cummings (San Francisco, USA)
Hal Ebetino (Rochester, USA)
Erik Eriksen (Oslo, Norway)
Allie Gartland (Sheffield, UK)
Peyman Hadji (Frankfurt, Germany)
Ingunn Holen (Sheffield, UK)
Bente Langdahl (Aarhus, Denmark)
Shelly Lawson (Sheffield, UK)
Eugene McCloskey (Sheffield, UK)
Socrates Papapoulos (Leiden, Netherlands)
Stuart Ralston (Edinburgh, UK)
Ian Reid (Auckland, New Zealand)
Mike Rogers (Sydney, Australia)

 

Topics

Topics to include

  • Historical aspects
  • Chemistry
  • Mechanisms of action
  • Pharmacology
  • Bone imaging
  • The bisphosphonate spectrum
  • Paget’s disease
  • Osteoporosis
  • Bone oncology
  • Myeloma
  • Osteoarthritis
  • Rare diseases
  • Dental aspects
  • Calcification
  • Pyrophosphate diseases
  • Ageing and life span
  • Epidemiology
  • Safety
  • Bisphosphonates for drug delivery
  • Legal aspects
  • Future directions

Venue

We are delighted to be hosting this anniversary meeting in the vibrant city of Sheffield, South Yorkshire. With its two universities, it has a world-class reputation for teaching and research, and the city is one of the UK’s greenest, and also one of the most lively. Although England’s 5th largest city, it is compact and easy to get around with plenty of good accommodation at affordable prices at walking distance from the conference venue and social events. A trip to Sheffield would not be complete without a trip to the nearby Peak District National Park, Britain’s first national park, established in 1951, a must for any walkers, cyclists, cavers, climbers or simply anyone who enjoys exploring the English countryside. From wild moorlands, through limestone dales, bustling market towns and pretty villages, the Peak District is an area of amazing variety and contrast. If you have time we would highly recommend a visit at the end or beginning of your stay.

Registration

Registration will open in autumn 2018.

Accommodation

Booking will open in autumn 2018.

Travel

By air
There are three airports within easy reach of Sheffield (approximately 1 hour travelling time), Manchester, Leeds Bradford and East Midlands.

London Heathrow and London Gatwick are also accessible by train with just one change in London.

By rail
The journey from London takes approximately 2 hours, while Manchester, Leeds and Birmingham are around 1 hour.

Contact

Janet Crompton
info@bisphosphonates2019.org

www.bisphosphonates2019.org

In association with the Mellanby Centre, University of Sheffield.